THe team that drives the science
Executive Team
Dr. T. Martin Schmeing, PhD
Dr. T. Martin Schmeing, PhD
Dr. T. Martin Schmeing, PhD
Chief Executive Officer
Dr. Martin Schmeing is a world-leading expert in the biochemistry and structure of proteins. Martin trained at McGill, Yale and Cambridge with two Nobel laureates. In addition to leadership at Canadienzyme, Martin is a professor in the Department of Biochemistry, where he publishes in the top journals and wins natio
Chief Executive Officer
Dr. Martin Schmeing is a world-leading expert in the biochemistry and structure of proteins. Martin trained at McGill, Yale and Cambridge with two Nobel laureates. In addition to leadership at Canadienzyme, Martin is a professor in the Department of Biochemistry, where he publishes in the top journals and wins national awards. Martin is the Canada Research Chair in Macromolecular Machines and the Director of the Centre de recherche en biologie structurale
Dr. Don van Meyel, PhD
Dr. T. Martin Schmeing, PhD
Dr. T. Martin Schmeing, PhD
Chief Scientific Officer
Dr. Don van Meyel is an internationally recognized biomedical scientist with expertise in neurobiology, cellular biology, and enzymatic reactions. Don obtained his PhD in Microbiology and Immunology at the University of Western Ontario, and his postdoctoral training in developmental neuroscience at the Salk Institu
Chief Scientific Officer
Dr. Don van Meyel is an internationally recognized biomedical scientist with expertise in neurobiology, cellular biology, and enzymatic reactions. Don obtained his PhD in Microbiology and Immunology at the University of Western Ontario, and his postdoctoral training in developmental neuroscience at the Salk Institute. In addition to leadership at Canadienzyme, Don is a professor in the Department of Neurology & Neurosurgery at McGill University, Don is the Director of the Centre for Translational Biology, the arm of fundamental research at the Research Institute of the McGill University Health Centre.
Stuart Kozlick, Eng, MASc
Dr. T. Martin Schmeing, PhD
Stuart Kozlick, Eng, MASc
Strategic Advisor
Stuart Kozlick is a Strategic Advisor and Executive-In-Residence within the Emerging Technology & Startup practice at Fasken Martineau DuMoulin LLP. An engineer and entrepreneur specializing in medical technologies, devices and healthcare systems, Stuart is called upon to lead strategic initiatives to integrate and develo
Strategic Advisor
Stuart Kozlick is a Strategic Advisor and Executive-In-Residence within the Emerging Technology & Startup practice at Fasken Martineau DuMoulin LLP. An engineer and entrepreneur specializing in medical technologies, devices and healthcare systems, Stuart is called upon to lead strategic initiatives to integrate and develop complex medical device systems in the clinical field. With 20 years of experience, Stuart has developed and accrued subject matter expertise in medical device development, innovation, research and commercialization. Over the course of his career, Stuart has led and launched several research, product development and clinical engineering programs and products globally. In addition to key roles at Canadienzyme, Stuart also is a Professor of Practice in the Department of Surgery, and a Faculty Lecturer in the Department of Mechanical Engineering, McGill University.